In honor of National Health Center Week, Roli Dwivedi, MD, in the Department of Family Medicine and Community Health, and fourth-year medical student Alycia Chmielewski, talk about their experience teaching, learning and caring for patients during the COVID-19 pandemic at the Community-University Health Care Center.
A University of Minnesota collaboration has resulted in a unique year-long fellowship known as the Minnesota Neuromodulation Medicine training program. Funded by MnDRIVE (Minnesota’s Discovery, Research, and InnoVation Economy), the program’s intent is to develop neurology, neurosurgery, psychiatry, and rehabilitation medicine specialists into competent, independent neuromodulation subspecialists.
The U of M Medical School, Duluth Campus Family Medicine Student Interest Group (FMIG) was recently recognized by the American Academy of Family Physicians with a 2020 Program of Excellence Award for exemplary efforts to grow and support interest in family medicine.
Erin Osterholm, MD, in the Department of Pediatrics, is leading a study to determine whether or not breast milk can act as a point of transmission for COVID-19. The study will examine if a newborn can contract the virus from their mother through breast milk if she is COVID-19 positive.
Wei-Shou Hu is working to create a cell line that can rapidly produce SARS CoV-2 spike proteins.
Please click here for a full list of recipients.
Michele L. Statz, PhD, assistant professor and anthropologist of law, collaborates with third-year medical student, Kaylie Evers to examine rural women's interpretations of rural distance as a multifaceted dimension of accessing healthcare.
Dr. Mustafa al’Absi, professor and licensed psychologist, recently published his findings in the International Review of Neurobiology looking at the long-term effects of stress and early-life adversity on addiction.
Anne Doering, MD, discusses her role as co-leader of the Resident Advocacy Cohort (RAC), which launched in 2019. This fall, the RAC will kick off its second cohort.
Ricardo Battaglino, PhD, in the Department of Rehabilitation Medicine, teamed up with fellow U colleagues to study the use of apilimod in treating COVID-19. Early results, using cell culture work, show that the drug is five times more effective than remdesivir.